2228 ⎘
Animals characterised by purpose; Animal model, e.g. for test or diseases Animal model comprising a reporter system for screening tests
Model animal in which state of disease condition is observable in real time, gene construct for achieving the same and use of the same
#302LexA-based chemical-inducible gene expression system for use in transgenic animals
#303METHODS, COMPOSITIONS AND TRANSGENIC MODELS RELATED TO THE INTERACTION OF T-CADHERIN AND ADIPONECTIN
#304Knockin mouse with a disruption in a PXR gene expressing human PXR
#305Blastomere culture to produce mammalian embryonic stem cells
#306Transgenic mice for assessing drug metabolism and toxicity
#307Targeted and regional cellular ablation in zebrafish
#308Method of deleting an IgM gene in an isolated rat cell
#309REGENERATION AND SURVIVAL OF CARDIAC PROGENITORS AND CARDIOMYOCYTES WITH A STRETCH ACTIVATED TRANSCRIPTION FACTOR
#310Method of determining chicken embryonic stem cells
#311Method for enabling stable expression of transgene
#312SOMATOTRANSGENIC BIOIMAGING
#313Ligand-regulable transactivation systems, methods of use thereof, methods of detecting estrogen receptor ligands, and methods of differentiating estrogen receptor ligand agonists and antagonists
#314Transgenic mice expressing humanized VEGF
#315Fluorescent mouse model
#316Xenobiotic related induction of gene expression
#317METHOD OF MONITORING RETINOPATHY
#318TRANSGENIC ANIMAL MODEL FOR MODELLING PATHOLOGICAL ANXIETY, A METHOD FOR IDENTIFYING COMPOUNDS FOR TREATMENT OF DISEASES OR DISORDERS CAUSED BY PATHOLOGICAL ANXIETY AND A METHOD FOR USING WFS1 PROTEIN AS A TARGET FOR IDENTIFYING EFFECTIVE COMPOUNDS AGAINST PATHOLOGICAL ANXIETY
#319RAPID IN VIVO MODEL FOR ANGIOGENESIS
#320RECOMBINANT CONSTRUCTS AND TRANSGENIC FLUORESCENT ORNAMENTAL FISH THEREFROM
#321Detection of cellular stress
#322Genetically modified animal for use in evaluating harmfulness of test substance
#323Transgenic Reporter Mouse and Method for Use
#324Methods for Conditional and Inducible Transgene Espression to Direct the Development of Embryonic, Embryonic Stem, Precursor and Induced Pluripotent Stem Cells
#325Methods for Assessing the Delivery of Exogenous Agents
#326Treatment of excessive neovascularization
#327METHODS FOR MODULATING EMBRYONIC STEM CELL DIFFERENTIATION
#328Probe for visualizing cell-cycle
#329Olig1 mini-promoters
#330RECOMBINANT CONSTRUCTS AND TRANSGENIC FLUORESCENT ORNAMENTAL FISH THEREFROM
#331Transgenic Frog Lines and Assays Employing Them
#332Rodent model of central neuropathic pain
#333Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#334Small animal model for hcv replication
#335Secreted proteins as markers for cell differentiation
#336OPTICAL DETECTION METHOD OR IMAGING METHOD OF IMPLANTED CELLS
#337Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation
#338SCREENING METHOD TO IDENTIFY PROTECTIVE SUBSTANCES FOR THE TREATMENT OF NEURODEGENERATIVE AND/OR ISCHAEMIC DISEASES
#339Methods for Identifying Functional Noncoding Sequences
#340Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation
#341LUMINESCENT STEM CELLS AND USES THEREOF
#342Development of a simple animal model for infection by viruses and other obligate intracellular parasites
#343Transgenic Zebrafish
#344Oligoribonucleotide inhibitors of NRF2 and methods of use thereof for treatment of cancer
#345METHODS FOR SCREENING FOR AGENTS THAT AFFECT DEVELOPMENT
#346Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
#347METHODS FOR TESTING ANTI-THROMBOTIC AGENTS
#348Composition and method for imaging cells
#349Transgenic Zebrafish Models for Neurodegenerative Diseases
#350Treatment of Conditions Involving Demyelination
#351HSC SELF-RENEWAL
#352Expression Vectors Comprising the HS1 Promoter of the VAV1 Oncogene and Use Thereof for the Preparation of Pharmaceutical Compositions Intended for Somatic Gene Therapy
#353TLR ligand and IL-1 Response-Injured Animal Model
#354DENDRITIC CELLS
#355NEW GENE FRAGMENT, NOVEL TRANSGENIC ZEBRAFISH AND METHODS FOR PRODUCING TRANSGENIC ZEBRAFISH
#356Transposition of maize AC/DS elements in vertebrates
#357Environmentally stable sensors and methods of using the same
#358Protein and peptide fragments from mouse telomerase reverse transcriptase
#359Non-invasive, in vivo fluorescent imaging of the nervous system in whole living animal
#360Method of disrupting heme transport in nematodes and of modelling and evaluating eukaryotic heme transport
#361TRANSGENIC ROSA26-LUCIFERASE MICE FOR BIOLUMINESCENT IMAGING
#362PNMT as a novel marker for progenitor cells
#363Transgenic or recombinant non-human mammals and their uses in screening psychoactive medicines
#364Cell Line and Methods for Determining Viral Titer
#365Non-invasive localization of a light-emitting conjugate in a mammal
#366METHODS FOR SCREENING INSECTICIDES
#367Recombinant constructs and transgenic fluorescent ornamental fish therefrom
#368Genomic DNA fragments containing regulatory and coding sequences for the B2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments
#369Trophectodermal cell-specific gene transfer methods
#370Role of alpha1-adrenergic receptors
#371Targeted delivery of glycine receptors to excitable cells
#372Fish cancer model
#373Systemic Treatment of Metastatic and/or Systemically-Disseminated Cancers using GM-CSF-Expressing Poxviruses
#374Phosphodiesterase 9 Inhibition as Treatment for Obesity-Related Conditions
#375Non-invasive real-time in vivo bioluminescence imaging of local Ca+ dynamics in living organisms
#376Screening method for somatic cell nuclear reprogramming substance affecting ECAT2 and ECAT3
#377Imaging reporters of transgene expression
#378Genetic manipulation method
#379Preprotachykinin Enhancer Elements
#380Transgenic Frog Lines and Assays Employing Them
#381sFRP expression enhancing agent
#382Polypeptide, novel DNA and novel antibody
#383Non-invasive localization of a light-emitting conjugate in a mammal
#384Large-Scale Production of Recombinant Transmembrane and Cytosolic Proteins
#385Methods and compositions for identifying cellular genes exploited by viral pathogens
#386MEMBRANE BOUND REPORTER GENE SYSTEM
#387Non-invasive methods and related compositions for identifying compounds that modify in vivo aggregations of disease-related polypeptides
#388Methods of screening agents for activity using teleosts
#389Transgenic animals for assessing drug metabolism and toxicity
#390Protein fragment complementation assays in whole animals applications to drug efficacy, adme, cancer biology, immunology, infectious disease and gene therapy
#391Compositions and methods for modulating hedgehog signaling
#392Animal Models for Cell Therapy and Cell Based Gene Therapy
#393Promotion of Cell Migration and Axon Regeneration in the Cns
#394Polycationic sterol derivatives as transfection agents
#395Method and composition for the site-selective delivery using viruses encapsulated in microbubbles
#396Sale of fluorescent transgenic ornamental fish
#397Method for isolating a self-renewing, multipotent, slow-cycling cell
#398Ligand-regulable transactivation systems, methods of use thereof, methods of detecting estrogen receptor ligands, and methods of differentiating estrogen receptor ligand agonists and antagonists
#399Methods and compositions for identifying biomarkers
#400Crustacean expression vector
#401Transgenic Mammals and Cell Lines for the Identification of Glutamate Transporter Modulators
#402Combinatorial marking of cells and cell structures with reconstituted fluorescent proteins
#403Non-human transgenic mammals useful for identifying and assessing neural stem/progenitor cells
#404Sequential reporter enzyme luminescence (SRL) methods and compositions for practicing the same
#405Excretable Reporter Systems
#406Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation
#407Methods of constructing a gene mutation library and compounds and compositions thereof
#408Rat embryonic stem cell
#409Transgenic mice containing Lrp5 gene disruptions
#410Protein fragment complementation assays for the detection of biological or drug interactions
#411Methods of screening agents for activity using teleosts
#412Disruptions in GABA Receptor RHO2 Subunit, Methods and Uses Thereof
#413Transgenic amphibian models for lymphatic vessel development
#414Compositions and methods for detecting and treating cancer
#415SREBP2gc transcription factors and uses thereof
#416Method for screening PTPzeta activity promoter or inhibitor
#417Transgenic Mice Containing GPCR5-1 Gene Disruptions
#418Versican and epithelial-mesenchymal interaction
#419TAAR1 knock out animal
#420Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses
#421Methods of obtaining neural stem cells
#422Cell line and methods for determining viral titer
#423Methods and compositions for in vivo inflammation monitoring
#424High-throughput functional analysis of gene expression
#425Model for studying the role of genes in tumor resistance to chemotherapy
#426SCREENING SYSTEMS AND METHODS FOR IDENTIFYING MODULATORS OF XENOBIOTICMETABOLISM
#427Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals
#428Cathepsin G (CTSG) Disruptions, Compositions and Methods Relating Thereto
#429Monitoring microrna expression and function
#430Sporadic tumor mouse model for drug discovery
#431Transgenic Mice Containing Kir3.3 Potassium Channel Gene Disruptions
#432Neural crest cells specific promoters; isolated neural crest cells; and methods of isolating and of using same
#433Transgenic mice containing mGluR7 metabotropic glutamate receptor gene disruptions
#434Transgenic mice containing lymphoid-specific GPCR gene disruptions
#435In vivo imaging of e2f-fegulated bioluminescent proteins
#436Method of disrupting heme transport in nematodes and of modelling and evaluating eukaryotic heme transport
#437Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
#438Transgenic mice containing SOCS-5 cytokine signalling suppressor gene disruptions
#439Transgenic mice containing channel activating protease 1 (CAP1) gene disruptions
#440Transgenic mice containing deubiquitinated enzyme gene disruptions
#441Transgenic mice containing MSK2 serine/threonine kinase gene disruptions
#442Transgenic mice containing adrenocorticotropin hormone receptor gene disruptions
#443Non-inbred embryonic stem cells having good developmental potential
#444Gene trap system
#445Transgenic mice containing melanocyte stimulating hormone receptor gene disruptions
#446Mouse cardiac conduction system model
#447Transgenic mice containing lumulus clotting factor protease-like gene disruptions
#448ADAM-like protease disruptions, compositions and methods related thereto
#449Functional assays for cholesterol absorption inhibitors
#450Transgenic mice containing, cGMP phosphodiesterase gene disruptions
#451GNG4 gene disruptions, compositions and methods related thereto
#452Transgenic mice containing CX2 gene disruptions
#453TRP6 calcium channel disruptions, compositions and methods related thereto
#454Transgenic mice containing sulfotransferase gene disruptions
#455Animal model for the fast identification of pharmaceutical active compounds in vivo
#456Transgenic mice containing anaphylatoxin C3a gene disruptions
#457OGR1 gene disruptions, compositions and methods relating thereto
#458Transgenic mice containing chordin gene disruptions
#459Assay methods for identifying RE2-like antagonists, methods of use, and non-human transgenic animals
#460Methods of screening agents for activity using teleosts
#461Assay methods for identifying modulators of OPSDL3 and transgenic knockouts
#462CYT28 serpentine receptor disruptions, compositions and methods relating thereto
#463Delta opioid receptor disruptions, compositions and methods related thereto
#464Transgenic mice containing glucocorticoid-induced receptor gene disruptions
#465Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto
#466Transgenic animal expressing HLA-A24 and utilization thereof
#467Transgenic mice containing NTTP1 phosphatase gene disruptions
#468Xenobiotic related induction of gene expression
#469Multi-reporter gene model for toxicological screening
#470Methods of screening agents for activity using teleosts
#471Transgenic mice containing beta3GalT2 gene disruptions
#472Transgenic mice containing TMEM3 beta-1,3-N-acetylglucosaminyltransferase gene disruptions
#473Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment
#474Transgenic mice containing CLCN4 chloride ion channel gene disruptions
#475Olfactory receptor expression libraries and methods of making and using them
#476Transgenic mice containing Kir5.1 inwardly rectifying potassium channel gene disruptions
#477Transgenic mice containing GPCR-like gene disruptions
#478Transgenic mice containing PAFR gene disruptions
#479Methods for producing proteins using silkworm middle silk gland-specific gene expression system
#480Methods for identifying a cell or an embryo carrying a Y chromosome
#481Transgenic mice containing chemokine receptor 9A gene disruptions
#482Methods and composition for modulating type I muscle formation using pgc-1 alpha
#483Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals
#484Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals
#485Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals
#486Promoter sequences for corticotropin releasing-factor receptor CRF2α and method of identifying agents that alter the activity of the promoter sequences
#487Transgenic animals expressing transglutaminase II
#488Zebrafish assay
#489Compositions comprising female germline stem cells and methods of use thereof
#490In vitro screening of cellular events using 3d cell culture systems
#491Cre-lox based method for conditional RNA interference
#492Non-invasive localization of a light-emitting conjugate in a mammal
#493Non-invasive real-time in vivo bioluminescence imaging of local CaÂ2+ dynamics in living organisms
#494Transgenic mice containing brain-specific membrane-anchored protein gene disruptions
#495Genetically modified non-human mammal cells, procedure for their production and use in toxicity tests
#496Screening method for identifying protective substances for treating neurodegenerative and/or ischemic disorders
#497Non-invasive localization of a light-emitting conjugate in a mammal
#498Regulatory sequences capable of conferring expression of a heterologous DNA sequence in endothelial cells and uses thereof
#499Induction and high-yield preparative purification of mesencephalic dopaminergic neuronal progenitor cells and dopaminergic neurons from human embryonic stem cells
#500Methods of screening agents for activity using teleosts
#501Assay for toxin induced neuronal degeneration and viability in
#502Prkag3 gene promoter and uses thereof
#503Method of screening compounds
#504Imaging regulated protein-protein interactions in cells and living animals by enhanced luciferase protein fragment complementation
#505Isolation and identification of transcription control elements associated with mouse eosinophil peroxidase expression
#506Isolation tool for viable c-kit expressing cells
#507Method for targeting transcriptionally active loci
#508Animal model for HCV infection
#509Transgenic zebrafish models for thrombosis
#510Compositions and methods for the treatment and diagnosis of immune disorders
#511Method of detecting disease conditions in infected with animal virus
#512NaCT as a target for lifespan expansion and weight reduction
#513Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy
#514P450 gene regulation
#515SiRNA mediated gene silencing in transgenic animals
#516Transgenic mice generated by transposition and uses thereof
#517Transgenic animal expressing hla-a24 and utilization thereof
#518LKB1 gene knockout animals
#519Imageable animal model of SARS infection
#520Transgenic animal model for cancer and stem cells
#521Monitoring APP cleavage in transgenic rodents comprising an APP-Swedish mutation
#522Screening methods employing fish model assessment of vision
#523Selective anesthetic agents and methods of identifying the same
#524Method for isolating cell type-specific mRNAs
#525High throughput screening for cancer genes
#526Method of screening for compounds that modulate activity of a regulatory sequence of the β-2 subunit of a neuronal nicotinic acetylcholine receptor
#527Tools to detect, track and target cancer cells in vivo
#528Neuronal activation in a transgenic model